Cognitive Behavior Therapy for Patients With Psychoses.
NCT ID: NCT03501888
Last Updated: 2018-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2015-10-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Cognitive Behavioral Therapy for Schizophrenia
NCT00300651
Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder
NCT06086184
Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions
NCT00358709
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
NCT00688259
Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis
NCT01876056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Scores on Alcohol Use disorder identification Test (AUDIT) and Drug Use disorder Identification Test (DUDIT) will be used as a covariate in order to control for the patients' s drug and alcohol use habits.
The study is single blind randomized controlled trials of manualized Cognitive Behavior Group Therapy (CBGT) versus an active treatment condition of individual CBT for patients with first episode psychosis. A total of 16 patients are enrolled and randomly allocated to either CBGT or to individual CBT treatment. Then 18 structured CBGT or individual CBT sessions approximately once a week will be offered. Three experienced CBT trained therapists will perform the therapies. Two therapists will be allocated to each group composed by approximately 5 patients.
The group therapies are conducted according to the Acceptance and Commitment Therapy (ACT) for psychosis manual (an 18 Session Group Therapy Protocol by Pearson A. \& Tingey R.). The individual therapies are conducted according to non-manualized ordinary clinical procedure. The ACT manual is originally constructed for patients with chronic schizophrenia and has therefore been adapted by the therapists to be appropriate for patients with first episode psychosis. The therapists have taken a course in ACT and they receive ACT-supervision during the trial.
Assessments in both studies will be carried out at baseline, after therapy completion and 6 months later by an independent rater blind to group allocation and not involved in the treatment of the patients. The raters blindness will be measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavior Therapy (CBT)
CBT: individually, ca 18 weeks.
Cognitive Behavior Therapy
18 sessions of individual treatment, no manual.
Acceptance and Commitment Therapy (ACT)
ACT: given in a group setting: ca 18 weeks.
Acceptance and Commitment Therapy
18 sessions of group treatment, manual based.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavior Therapy
18 sessions of individual treatment, no manual.
Acceptance and Commitment Therapy
18 sessions of group treatment, manual based.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* schizophrenia,
* schizophreniform psychosis,
* schizoaffective disorder)
* delusional disorder,
* brief psychotic disorder
* psychosis not otherwise classified.
Exclusion Criteria
* organic brain injury,
* patients with grave somatic illness with secondary psychotic symptoms.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helena Fatouros-Bergman
Pricipal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena Fatouros-Bergman, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Insitutet
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Karolinska Inst
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.